- Home
- CTSO vs WIMI Comparison
CTSO vs WIMI Comparison
Compare CTSO & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- WIMI
- Stock Information
- Founded
- CTSO 1997
- WIMI 2015
- Country
- CTSO United States
- WIMI China
- Employees
- CTSO N/A
- WIMI N/A
- Industry
- CTSO Medical/Dental Instruments
- WIMI Computer Software: Prepackaged Software
- Sector
- CTSO Health Care
- WIMI Technology
- Exchange
- CTSO Nasdaq
- WIMI Nasdaq
- Market Cap
- CTSO 45.3M
- WIMI 38.3M
- IPO Year
- CTSO N/A
- WIMI 2020
- Fundamental
- Price
- CTSO $0.64
- WIMI $3.02
- Analyst Decision
- CTSO Buy
- WIMI
- Analyst Count
- CTSO 2
- WIMI 0
- Target Price
- CTSO $5.38
- WIMI N/A
- AVG Volume (30 Days)
- CTSO 106.4K
- WIMI 142.4K
- Earning Date
- CTSO 11-13-2025
- WIMI 01-01-0001
- Dividend Yield
- CTSO N/A
- WIMI N/A
- EPS Growth
- CTSO N/A
- WIMI N/A
- EPS
- CTSO N/A
- WIMI 1.43
- Revenue
- CTSO $36,979,520.00
- WIMI $61,329,146.00
- Revenue This Year
- CTSO $11.93
- WIMI N/A
- Revenue Next Year
- CTSO $21.22
- WIMI N/A
- P/E Ratio
- CTSO N/A
- WIMI $2.02
- Revenue Growth
- CTSO 20.75
- WIMI N/A
- 52 Week Low
- CTSO $0.60
- WIMI $2.24
- 52 Week High
- CTSO $1.61
- WIMI $9.66
- Technical
- Relative Strength Index (RSI)
- CTSO 24.35
- WIMI 33.23
- Support Level
- CTSO $0.60
- WIMI $2.86
- Resistance Level
- CTSO $0.70
- WIMI $3.29
- Average True Range (ATR)
- CTSO 0.06
- WIMI 0.20
- MACD
- CTSO -0.01
- WIMI -0.03
- Stochastic Oscillator
- CTSO 5.54
- WIMI 16.26
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.